Recent News for ZLAB - Zai Lab Limited

Date Title
Aug 14 Zai Lab Appoints Professor Kai-Xian Chen, Ph.D., to its Board of Directors
Aug 8 FDA Ad Com backs Paratek's omadacycline for ABSSSI
Jun 29 Zai Lab Announces Dosing of First Patient in Phase 3 China Registration Trial of ZL-2306 (niraparib) for First-Line Maintenance Therapy in Platinum Responsive Ovarian Cancer
Jun 7 Pfizer's marketing applications for PARP inhibitor talazoparib accepted in U.S. and Europe
Jun 5 Zai Lab Expands Commercial Leadership Team, Appoints William Liang as Chief Commercial Officer
Jun 3 The Week Ahead In Biotech: ASCO Presentations Dominate The Headlines
May 30 Zai Lab in-licenses topical anti-inflammatory biologic candidate from Crescendo
May 30 Zai Lab and Crescendo Biologics Enter Exclusive Worldwide License Agreement for Innovative Protein Therapeutics for Inflammatory Indications
May 29 Zai Lab Announces Presentations at June Investor Conferences
May 21 Zai Lab Announces Early Completion of Enrollment for ZL-2306 PK Study
May 18 Zai Lab (ZLAB) Presents At Bank Of America Merrill Lynch 2018 Healthcare Conference - Slideshow
May 2 Zai Lab reports FY results
May 2 Zai Lab Reports Full Year 2017 Financial Results and Corporate Update
Apr 27 Blog Exposure - Zai Lab Inks Exclusive License Deal with Entasis for ETX2514 in the Asia/Pacific Region
Apr 25 Zai Lab in-licenses Entasis Therapeutics' broad-spectrum antibiotic in Asia-Pacific; shares up 3%
Apr 25 Entasis Therapeutics and Zai Lab Announce Exclusive License Agreement in Asia-Pacific and Global Strategic Development Collaboration for ETX2514
Apr 24 Zai Lab Limited Announces Presentations at May Investor Conferences
Mar 14 Zai Lab: A Short Ahead Of Lockup Expiration
Mar 5 Zai Lab Limited Appoints Billy Cho as Chief Financial Officer
Mar 5 China's Tasly to list biotech arm in $1 bln Hong Kong IPO - sources
Feb 21 Should You Be Concerned About Zai Lab Limited’s (NASDAQ:ZLAB) Shareholders?
Jan 12 PARP competitors under pressure as AstraZeneca nabs U.S. OK for Lynparza in breast cancer
Nov 23 Zai Lab Limited (ZLAB): Is Now The Time To Bet On Healthcare?
Nov 8 Why Zai Lab Limited’s (ZLAB) Investor Composition Impacts Your Returns
Oct 28 Stocks to watch next week

Back to the Main ZLAB Page...